Reuters logo
2 个月前
BRIEF-Amunix Operating Inc says FDA has accepted Bioverativ's IND application for BIVV001
2017年6月14日 / 上午11点13分 / 2 个月前

BRIEF-Amunix Operating Inc says FDA has accepted Bioverativ's IND application for BIVV001

June 14 (Reuters) - Bioverativ Inc

* Bioverativ announces FDA acceptance of investigational new drug application for BIVV001, a novel, long-acting FVIII hemophilia therapeutic utilizing amunix XTEN® half-life extension technology

* Amunix Operating Inc says FDA has accepted Bioverativ's IND application for BIVV001 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below